TRDA
Entrada Therapeutics, Inc. · Healthcare
CFO Kory James Wentworth sold $64K of Entrada Therapeutics, Inc.
Sold$64,362
$13.78Price
4,669Shares
−30%Stake
What TRDA did after the filing
- The stock from Fri, Aug 26 close, $14.56
- +0.6%
- S&P 500, same days
- −10.8%
Measured over 30 trading days, to the Oct 10 close.
Traded Wed, Aug 24. Filed Fri, Aug 26, 12:06 PM ET, during the session. Returns use the Aug 26 close and the Oct 10 close. Not investment advice.